MAP Indonesia
Established in 1995, MAPI is a leading Indonesian lifestyle retail group with substantial retail operations across Indonesia and Southeast Asia.
The group has built partnerships with international brands and has a diversified portfolio that includes sports, fashion, department stores, kids, food & beverage and lifestyle products.
Case Studies
PT Samator Indo Gas
Samator Indo Gas is the largest industrial and medical gas company in Indonesia.
With a distribution network, strategically located across the country, including pipeline, bulk and cylinder, Samator are the only gas supplier in Indonesia to offer total customer solutions to hospitals and other healthcare institutions. Their customer base extends beyond medical to retail, consumer goods, infrastructure and other manufacturing customers.
RKE International
With over 25 years' experience, RKE International is a leading toll road operator in Indonesia.
The company currently manages a portfolio of three expressways in Indonesia, all located in major economic corridors.
Siloam International Hospitals
Siloam International Hospitals is the leading private hospital operator in Indonesia both in terms of size and quality of medical services and facilities.
The company began operations in 1996 and currently operates 41 hospitals. Siloam's existing hospitals are equipped with state of the art equipment and the latest medical technology in Indonesia.
The company also has a strong brand recognition among both doctors and patients alike, and is considered the preferred choice for the middle and affluent segments of the population.
SOHO Global Health
SOHO Global Health is a leading domestic player in the Indonesian branded consumer health/over-the-counter pharmaceutical sector, focusing on herbal medicine supplements in Indonesia.
Founded in 1946, Soho has a strong track record of growth and holds leading positions in multiple market categories. The business also wholly owns the fifth largest pharmaceutical distributor in the country, selling both Soho's owned products and third-party principal brands.
The selected companies are presented solely to illustrate the types of investments that may be made by CVC for one or more strategies, and are not representative of all transactions of any given strategy. References to a particular investment should not be considered a recommendation by CVC. The investments presented were made under market, economic and supply-demand conditions which may not be replicated, and future investments may have characteristics that differ from the case studies presented here. Consequently, there can be no assurance that CVC funds will be able to invest in similar opportunities in the future. It should not be assumed that the case studies presented here or that any investments made in the future were or will be profitable.